Efficacy and Safety of Short-term Intravenous Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients Treated With Beta-receptor Blocking Agents.
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine
- Indications Chronic heart failure
- Focus Therapeutic Use
- Sponsors Orion
- 22 Mar 2017 New trial record